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Solution NMRPhospholamban (PLN) is a dynamic single-pass membrane protein that inhibits the ﬂow of Ca2+ ions into the
sarcoplasmic reticulum (SR) of heart muscle by directly binding to and inhibiting the SR Ca2+ATPase (SERCA).
The PLN monomer is the functionally active form that exists in equilibrium between ordered (T state) and
disordered (R state) states. While the T state has been fully characterized using a hybrid solution/solid-state
NMR approach, the R state structure has not been fully portrayed. It has, however, been detected by both NMR
and EPR experiments in detergent micelles and lipid bilayers. In this work, we quantitatively probed the μs to
ms dynamics of the PLN excited states by observing the T state in DPC micelles using CPMG relaxation
dispersion NMR spectroscopy under functional conditions for SERCA. The 15N backbone and 13Cδ1 Ile-methyl
dispersion curves were ﬁt using a two-state equilibrium model, and indicate that residues within domain Ia
(residues 1–16), the loop (17–22), and domain Ib (23–30) of PLN undergo μs-ms dynamics (kex=6100±
800 s-1 at 17 °C). We measured kex at additional temperatures, which allowed for a calculation of activation
energy equal to ∼5 kcal/mol. This energy barrier probably does not correspond to the detachment of the
amphipathic domain Ia, but rather the energy needed to unwind domain Ib on themembrane surface, likely an
important mechanism by which PLN converts between high and low afﬁnity states for its binding partners.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Regulation of heartmuscle contractility is a dynamic event requiring
molecular control over the concentration of intracellular calcium. This
process is primarily carried out by the ryanodine receptors, which
release Ca2+ from the sarcoplasmic reticulum (SR), and Ca2+-ATPase
(SERCA), which pumps Ca2+ into the SR. SERCA is inhibited by an
integralmembrane protein phospholamban (PLN) in cardiacmuscle [1].
Phosphorylation at Ser16 and/or Thr17 relieves inhibition, allowing for
full viability of SERCA [2]. It has been shown that phosphorylated Ser16
PLN(pS16-PLN) causes apartial order-to-disorder transition resulting in
an alteration of all four of the PLN dynamic domains: Ia (residues 1–16),
loop (residues 17–22), Ib (residues 23–30), and II (residues 31–52) [3].
In the absence of SERCA, PLN exists in equilibrium between a
dynamically ordered T state (Fig. 1, PDB 2KB7 [4]) and a dynamically
disordered R state [5,6]. The T state is the most populated in both lipid
bilayers and detergent micelles [7,8], having a population of 84%
measured by EPR in DOPC/DOPE lipid bilayers [9]. While the T and R
states are both able to bind SERCA [10], the R state likely has a higherlasmic reticulum Ca-ATPase,
olis, MN 55455, USA. Tel.: +1
ll rights reserved.afﬁnity for the enzyme [11,12], as well as being necessary for
recognition of its other binding partners, e.g., protein kinase A (PKA),
Ca2+/calmodulin-dependent kinase II (CAMKII), and A-kinase an-
choring protein (AKAP) [13]. Understanding the dynamics for this T to
R state equilibrium is necessary to rationalizing how these states play a
role in SERCA regulation and thus Ca2+ concentrations within the cell.
NMR spin relaxation measurements give insight into local and
global dynamics of proteins over a wide range of timescales (ps to s)
under native-like conditions [14–18]. An important dynamic time-
scale that has been correlated with catalytic activity is μs to ms motion
[19–24]. Toprobe this dynamics, theuseof Carr–Purcell–Meiboom–Gill
(CPMG) and spin-locking relaxation dispersion experiments (T1ρ) are
valuable [25–28]. In our previous work, we quantitatively character-
ized the dynamics of PLN on the ps to ns timescale and qualitatively
showed PLN to exhibit slow dynamics [3,6]. In this study, we illustrate
the kinetic and thermodynamic parameters for the PLN excited states
by quantifying slow μs to ms dynamics using backbone 15N and Ile-
methyl group 13Cδ1 CPMG relaxation dispersion measurements.
2. Materials and methods
2.1. Protein production
A fully functional monomeric mutant of PLN (C36A, C41F, C46A,
AFA-PLN) was expressed [U-15N] and [13Cδ1-Ile] using 15NH4Cl and 2-
Fig. 1. Structure of the T state of monomeric AFA-PLN in a DOPC lipid bilayer derived
from the hybrid solution and solid-state NMRmethod (PDB 2KB7) [4]. The four dynamic
domains of AFA-PLN are denoted on the structure.
Fig. 2. 15N CPMG dispersion curves at 600 (circles, 14.1 T) and 800 MHz (squares,
18.7 T) for selected residues of AFA-PLN at 17 °C. Best ﬁts to Eq. (1) are plotted with the
data. The error bars indicate the standard deviation from duplicate experiments at each
value of νCPMG.
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previously described [29,30]. After HPLC puriﬁcation, the protein was
lyophilized with the subsequent powder stored at −20 °C until
sample preparation.
2.2. Sample preparation
AFA-PLN samples were dissolved to a concentration of 1 mM in
300 mM DPC, 120 mM NaCl, 20 mM sodium phosphate (pH 6.0), and
0.01% NaN3 as previously used by our laboratory in several papers
[3,30,31]. These samples were stable for several weeks over the
temperature range used in these studies.
2.3. NMR spectroscopy
Spin relaxation experiments were performed using two AFA-PLN
samples: 1) [U-15N], [13Cδ1-Ile] and 2) [U-15N]. Single quantum 15N
CPMG experiments with temperature compensation were carried
out at B0=14.1 and 18.7 T using relaxation compensated HSQC [32]
and TROSY pulse sequences [33,34] with constant time delays of 20
and 40 ms, respectively. The 20 ms time was needed at 12 °C for the
[U-15N] sample to increase signal to noise. The time spacing between
the 180° pulse centers is equal to 2τcp, which is expressed as a
frequency (νCPMG) equal to 1/(4τcp). For the ﬁrst sample, 2D
datasets were acquired for νCPMG=50(×2), 100, 150, 200, 250,
300, 350, 400 (×2), 450, 500, 600, 700, 800, 900, 1000 (×2) Hz at
B0=14.1 and 18.7 T (at 17 °C). For the second sample, spectra were
acquired in duplicate for νCPMG=50, 100, 150, 200, 300, 400, 500,
600, 700, 800, 900, and 1000 Hz at B0=14.1 T, and in duplicate
for νCPMG=50, 100, 200, 300, 400, 500, 600, 800, and 1000 Hz at
B0=18.7 T (at 17 °C). In order to assess the backbone exchange
kinetics as a function of temperature, we acquired CPMG dispersion
data at 12, 17, and 22 °C using a constant time delay of 20 ms in
triplicate using νCPMG=100, 200, 300, 500, 700, and 1000 Hz at
both B0=14.1 and 18.7 T (see Supporting Information Fig. 1).
The 13C multiple quantum relaxation experiments [35] were all
performed at B0=14.1 T with a constant time delay of 40 ms using
νCPMG values at the following temperatures: 5 °C [50(×2), 100, 150,
700, 800, 900, 1000 (×2)], 10 °C, 20 °C, and 37 °C all with [50, 100
(×2), 150, 200, 250, 300 (×2), 350, 400, 450, 500, 600, 700, 800 (×2),900, 1000 Hz]. Reference spectra were acquired with no constant time
delay for each of the experiments.
Room temperature triple-axis gradient HCN Varian probes were
used for all measurements, except one set of data using a [U-15N]
sample at B0=18.7 T, in which a Varian cold-probe was used.
Due to a slight detuning of the 15N channel on the cold-probe at
larger values of νCPMG, we applied a linear correction to those
residues that showed dispersion (see Supporting Information
Fig. 2). This correction was calculated from residues that did not
show an exchange contribution to relaxation on the room
temperature probes, and was relatively minor (∼2 Hz difference
in R2eff for νCPMG=50 Hz and νCPMG=1000 Hz). R2eff was calcu-
lated using the following relationship: R2eff =
−lnfI vCPMGð Þ
I0
1
T, where
I(νCPMG) is the intensity for a given value of νCPMG, I0 is the inten-
sity of the reference spectrum, and T is the constant time delay. All
errors reported in the ﬁgures are standard deviations from multiple
experiments, or in cases where no duplicate or triplicate existed, the
average of the standard deviation for points that were repeated.
A 100% methanol standard was used to calibrate the tempera-
ture on the spectrometers. All of the experiments were acquired
with Varian spectrometers (VNMRS for B0=14.1 T and INOVA for
B0=18.7 T), with the data processed in NMRPipe [36] and peak-
picked in Sparky [37].
3. Results
Our previous data on the μs–ms dynamics on AFA-PLN were
acquired at B0=18.7 T and a temperature of 37 °C [3,6]. While these
measurements qualitatively showed PLN to display slow dynamics,
the ΔR2 dispersions were rather small. In the new experiments, we
ﬁrst performed dispersionmeasurements at B0=14.1 T and 37 °C, but
found all residues to show dispersions b 2 Hz. As the temperature was
Table 1
Results from a global kex ﬁt from 15N single quantum dispersion curves using the fast
chemical exchange equation (Eq. (1)).
kex (s−1)
12 °C 17 °C 22 °C
6000±600 6100±800 8100±700
The errors bars reﬂect an 85% conﬁdence interval.
Fig. 4.Methyl group CPMG dispersion curves at B0=14.1 T for Ile18 13Cδ1 for AFA-PLN
at 5 °C (ﬁlled squares), 10 °C (ﬁlled circles), 20 °C (open squares), and 37 °C (open
circles). Best ﬁts to Eq. (1) assuming fast exchange are plotted with the data. The error
bars are within the data points.
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number of residues. Interestingly, as the temperature was decreased
from 37 °C, Thr17 and Ala24 became signiﬁcantly broadened, which
alone indicates a relaxation contribution from chemical exchange
(Rex), as anticipated by both NMR [3,6] and EPR data [5]. To assess kex
as a function of temperature (12, 17, and 22 °C) we acquired 15N
dispersion curves at B0=14.1 and 18.7 T. The data are shown in Fig. 2
and Supporting Information Fig. 1, where the error bars reﬂect the
standard deviation between two (Fig. 2) or three identical experi-
ments (Supporting Information Fig. 1) for each value of νCPMG
collected in an interleaved manner.
A total of seven residues (Ser16, Thr17, Gln22, Gln23, Arg25, Gln26,
and Asn27) display dispersion curves withΔR2N2 Hz (i.e., dispersion),
where ΔR2=R2eff(νCPMG=50 Hz)−R2eff(νCPMG=1000 Hz). These
residues are located within three domains of PLN (the loop and
domains Ia and Ib). From the data shown in Fig. 2,ΔR2 for B0=14.1 and
18.7 T change by the expected quadratic scaling (∼1.78) for fast
exchange (Δω2; see below). Therefore, all residues were ﬁt to a two-
site fast exchange model (Eq. (1)) to extract kinetic information from
the dispersion curves [38].
R2eff vCPMGð Þ = R2 +
uex
kex
1− 4vCPMG
kex
tanh
kex
4vCPMG
  
ð1Þ
uex = pApBΔω2, pA and pB are the populations of the two states, Δω is
the chemical shift difference between states A and B, kex is the
exchange rate (sum of forward and reverse rate constants for the
A⇔B equilibrium), and R2 is the intrinsic relaxation rate (assumed to
be the same for states A and B). A least-squares ﬁt to Eq. (1) was
carried out in Mathematica to extract kex, R2, and φex for individual
residues (at both magnetic ﬁelds) as well as a global ﬁt [39]. The
global ﬁt was performed by simultaneously minimizing kex for all
residues at both magnetic ﬁelds (Table 1). Importantly, the global kex
values and the average values are in good agreement. The global kex
values are 6000±600 (12 °C), 6100±800 s−1 (17 °C), and 8100±
700 for Ser16, Thr 17, Gln22, Gln23, Arg25, Gln26, and Asn27. The
error bars reﬂect an 85% conﬁdence interval.
As shown in Supporting Information Fig. 1, the HSQC-CPMG pulse
sequence from Loria et al. [32] gave ﬁeld-dependent R2 values for all
the residues, even those that did not experience chemical exchange
(data not shown). In the absence of a correction factor, the data ﬁttingFig. 3. Arrhenius plot for the 15N CPMG dispersion data (red triangles—global kex ﬁt;
black squares—average kex values). Error bars reﬂect the 85% conﬁdence interval from
global ﬁts and the standard deviation from averaging the residue-dependent kex values.gave inconsistent values of kex relative to those determined using the
TROSY CPMG sequence (no correction was needed for these
experiments) [33,34]. For this reason, a correction factor was applied
to R2 for all residues experiencing chemical exchange in Eq. (1) (a
global ﬁt).
From the exchange rates reported in Table 1, an Arrhenius plot was
constructed (Fig. 3) to determine the activation energy for the T state
to an excited state. From the plot, we calculated an activation energy
of ∼5 kcal/mol.
In addition to the backbone 15N CPMG dispersion curves, we also
carried out dispersion analysis for Ile-methyl groups in AFA-PLN.
Since the methyl groups are less sensitive to helical folding and
more to electrostatic environment (hydrophobic packing, solvent
structure, etc.), they are a better probe to test the solvent
accessibility of PLN domains Ia and Ib. Within the Ile 13Cδ1 spectra,
the residues that gave dispersion were Ile12 and Ile18 (out of the
8 Ile methyl groups within PLN). Similar to the results for the
backbone 15N sites, Ile12 and Ile18 did not show signiﬁcant
dispersion at 37 °C at B0=14.1 T. Upon decreasing the temperature,
the methyl groups became quite sensitive to the dynamics, showing
substantial dispersion (Fig. 4). Unfortunately, the Ile12 13Cδ1
resonance became substantially broadened at temperatures below
20 °C, leading to noisy dispersion data.
4. Discussion
The presence of the T and R states has been shown to be critical in
the regulation of SERCA [10,12]. While the T state appears to be an
inhibitory form of SERCA, the R state seems more important in the
relief of SERCA regulation, as shown by Thomas and co-workers using
an N-terminal lipid anchored PLN molecule (∼100% T state) [10]. This
knowledge encouraged the design of PLN mutants that might be able
to lower the activation energy barrier to the R state, or simply increase
the population of the R state, i.e., better mimic the R state [31]. This
research is ongoing, and continues to be a promising path toward the
design of therapeutic mutants that not only might overcome the
effects of endogenous loss or gain-of-function PLN mutants, but also
assist in the recovery of damaged heart muscle tissue.
Previously, our analysis of T1, T2, and heteronuclear NOE experi-
ments for monomeric PLN showed the existence of two dynamically
dissimilar domains within the single α-helix comprised of residues
22-52 [6]. The primary sequences of PLN agreewell with this expected
hydrophobic mismatch. Domain Ib is comprised of several hydrophilic
and charged amino acids (Gln23, Ala24, Arg25, Gln26, Asn27, Leu28,
Gln29, Asn30), while domain II is mainly comprised of hydrophobic
amino acid residues (Leu, Ile, Val, and Phe). While the ﬁrst structure
reported by our laboratory in detergent micelles did not show the
depth of insertion with respect to the membrane [7], our new
structure exempliﬁes the dissimilarity of domains Ib and II in terms of
dynamics and depth of membrane insertion (Fig. 1) [4,40]. The
solvent exchange data also agree with this structure, as domain Ib
Fig. 5.Model of detaching/unfolding of monomeric PLN, which is consistent with CPMG
dispersion data presented in this work as well as ﬁndings reported on the R state [42].
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perdeuterated growths of PLN [30], the majority of residues within
domain II have attached deuterons to the amide nitrogen throughout
the protein puriﬁcation (3–4 days). Only upon unfolding of the
protein and elevated temperature do these sites exchange with H2O.
Domain Ib (residues 23–30) is well-known to be important in
the regulation of SERCA [41]. Alanine-scanning mutagenesis
indicates that most mutations in this region give rise to PLN
mutants with gain-of-function, i.e., more inhibition [41]. In this
work, we quantitatively assessed the chemical exchange of the T
state of PLN, through the use of CPMG relaxation dispersion
measurements. Our results indicate that several residues in domain
Ib show dynamics in the μs to ms timescale. However, the observed
exchange rates reported for PLN in Table 1 are not likely a simple
exchange between T and R states, at least not for both amide
backbone sites and side chain methyl groups. The reason is that in
the methyl group spectrum of AFA-PLN, we detected both the T and
R states for residues in domain Ia (i.e., slow exchange) [42]. Since
we observed dispersion for Ile12 and Ile18 methyl groups at the
13Cδ position (Fig. 4), this means that the T state is in fast chemical
exchange with another state. On the other hand, the backbone
amide sites of the R state are not in slow exchange, which reﬂects
the fact that the chemical shift differences (Δω) are smaller than for
the methyl groups [11,12] Fig. 5 shows an unfolding model where
we suggest an intermediate in the energy landscape toward the full
R state. The ﬁrst step depicts a partial unwinding of domains Ia and
Ib (kex in fast chemical exchange) followed by a partial unwinding
and detachment of domain Ia from the membrane (kex in slow
chemical exchange [42]). This mechanism is similar to proposed
models for the folding and unfolding of amphipathic antimicrobial
peptides and proteins [43]. Therefore, assuming that domain Ib is
similar in structure for the intermediate and ﬁnal R state, the
chemical exchange kinetics reported are reﬂective of the T to R state
transition for backbone atoms, which would have an activation
energy barrier of ∼ 5 kcal/mol as measured by our CPMG
experiments. Although this needs to be further investigated, domain
Ib unwinding is supported by a model of PLN bound to SERCA
(model by MacLennan and Toyoshima [44]) as well as the
hypothesis that PLN needs to extend and potentially be pulled up
from the membrane to interact with SERCA ([10]). The reported
activation energy also is quite similar to those reported for
amphipathic membrane peptides and proteins [43,45–50].
These new data further elucidate the dynamic picture of PLN,
emphasizing the role of the loop and domains Ia and Ib in the partial
unfolding process that may be needed to enable PLN to mold into the
SERCA enzyme. The conformational dynamics of PLN is preserved in
the presence of SERCA, where both T and R states have been detected
by EPR [10]. Therefore, we propose that the inhibitory process occurs
through a shift of the conformational equilibrium of T and R PLN states
rather than through discrete (static) conformational states (free and
bound).
Importantly, the conformational equilibrium of PLN between T and
R states is tunable [31]. Ser16 phosphorylation of PLN, targeted
mutations in the dynamic loop [31], and lipid membrane composition
[51] have direct repercussions in SERCA afﬁnity for calcium. In ourrecent paper [31], we used this information to design loss-of-function
mutants of PLN to be tested in gene therapy, and proposed that new
mutants must be promoted to the excited state (R state) for binding
SERCA more effectively. In our previous work, however, we limited
our functional manipulation and the rational mutagenesis to the
dynamic loop of PLN. These new dynamics data implicate several
residues in domains Ia and Ib that need to be incorporated to our
existing knowledge database in order to design other PLN mutants
that are more effective (better binder and loss-of-function) than the
P21G mutant previously reported [31].
These studies stress the importance of dynamics in the functional
characterization of the ground and excited states of small regulatory
integral membrane proteins, enabling the progression of structural
biophysics from understanding the biological phenomena to control-
ling the function.
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